PMA supplement
P000025 S019: COMBI 40+ SYSTEM WITH C40+ OR PULSARCI100 COCHLEAR IMPLANTS
FDA PMA supplement · Real-Time Process · Med-El Corp.
Key facts
| Original PMA | P000025 |
|---|---|
| Supplement number | S019 |
| Supplement type | Real-Time Process |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | COMBI 40+ SYSTEM WITH C40+ OR PULSARCI100 COCHLEAR IMPLANTS |
| Generic name | Implant, cochlear |
| Applicant | Med-El Corp. |
| Product code | MCM |
| Received date | Jul 5, 2005 |
| Decision date | Jul 25, 2005 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: